In:
Acta Endocrinologica, Oxford University Press (OUP), Vol. 122, No. 5 ( 1990-05), p. 592-598
Kurzfassung:
The inhibitory effects of pyridoglutethimide (3-ethyl-3-(4-pyridyl)piperidine-2,6-dione), an analogue of aminoglutethimide, on aromatase and other cytochrome P-450-dependent steroid-metabolizing enzymes were studied in vitro. Pyridoglutethimide and aminoglutethimide showed competitive inhibition of human placental aromatase activity with apparent K i values of 1.7 and 0.7 μmol/l, respectively. Both pyridoglutethimide and aminoglutethimide inhibited the aromatase activity of uterine leiomyoma and cultured choriocarcinoma Enami cells as well as immunopurified human placental aromatase cytochrome P-450 by more than 90%, with IC 50 values of 10–19 and 5–7 μmol/l, respectively. These results might suggest that the inhibitors interacted directly with the aromatase cytochrome P-450 of these tissues. Aminoglutethimide inhibited bovine adrenal cholesterol side-chain cleavage activity with an IC 50 value of 40 μmol/l and inhibited 21-hydroxylase activity slightly, but did ot inhibit 17α-, 1 1β- and 18-hydroxylase at concentrations up to 100 μmol/l. On the other hand, pyridoglutethimide had no inhibitory effect on any of these enzymes at concentrations up to 50 μmol/l, although it inhibited 11β- and 18-hydroxylase slightly at 100 μmol/l. These results indicated that pyridoglutethimide was an aromatase inhibitor of a comparable potency to aminoglutethimide, but that it did not inhibit other steroid hydroxylases.
Materialart:
Online-Ressource
ISSN:
0804-4643
,
1479-683X
DOI:
10.1530/acta.0.1220592
Sprache:
Unbekannt
Verlag:
Oxford University Press (OUP)
Publikationsdatum:
1990
ZDB Id:
1485160-X